Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors
================================================================================================================================================================================================================================================

* Charlotte Lemech
* Keith Dredge
* Darryn Bampton
* Edward Hammond
* Andrew Clouston
* Nigel J Waterhouse
* Amanda C Stanley
* Lucie Leveque-El Mouttie
* Grace M Chojnowski
* Andrew Haydon
* Nick Pavlakis
* Matthew Burge
* Michael P Brown
* David Goldstein